Imagers know that you can skip the contrast in heavier patients undergoing CT scans for suspected appendicitis, but just how heavy is heavy enough?
Imagers know that you can skip the contrast in heavier patients undergoing CT scans for suspected appendicitis, but just how heavy is heavy enough?
Researchers at McMaster University in Ontario, Canada, have developed one indicator: body girth. In a scientific paper presented Tuesday, they reported that in patients with an abdominal girth of 105 cm or more, it is safe to skip the contrast and still get a good image of the appendix.
In CT scans, abdominal fat helps visualize the appendix. Without the fat, contrast is needed to bring out the organ.
Investigators retrospectively evaluated unenhanced helical CT scans of 108 patients to determine whether a normal appendix could be identified by both a radiology resident and a staff abdominal radiologist. They developed a computer program to estimate abdominal girth at the level of the iliac crests, said Dr. Kelly Ainsworth, the presenter and a fourth-year radiology resident.
The appendix was seen in 74 patients and not seen in 34. A statistical analysis determined that abdominal girth averaged 19.42 cm larger in those patients in whom the appendix was visible (p <0.001) than in those in which it was not visible. An ROC analysis demonstrated that for those whose abdominal girth is greater than 105 cm (p <0.001), an unenhanced CT scan adequately identifies the appendix.
Besides reducing the risk attendant on contrast injection, an unenhanced scan also reduces the time needed to administer and wait for the contrast. In slim patients, ultrasound or contrast CT is necessary, Ainsworth said.
Ainsworth was asked about other potential measures, such as body mass index. She said the facility is continuing its research into other indicators, including visceral fat.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.